How Can Pharmacists Approach Reimbursement Challenges to Improve Biosimilar Use?
At the 2018 ASHP Midyear Clinical Meeting and Exhibition, Ashley Mains Espinosa, PharmD, Director of System Pharmacy Business Services at SCL Health, offered advice on how pharmacy providers can work to overcome biosimilar reimbursement challenges and encourage biosimilar adoption.
At the 2018 ASHP Midyear Clinical Meeting and Exhibition, Ashley Mains Espinosa, PharmD, Director of System Pharmacy Business Services at SCL Health, offered advice on how pharmacy providers can work to overcome biosimilar reimbursement challenges and encourage biosimilar adoption.
Transcript
"Pharmacy providers can educate themselves on the revenue cycle process. Partnering with your finance experts at your hospital, or your health system or clinic, can help pharmacists and finance folks approach these challenges in order to encourage and improve biosimilar adoption. Additionally, pharmacy providers can educate patients, other stakeholders, and providers on the benefits of these therapies, as well as things they should know in order to continue its use."
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- IMS 2025: Improving Outcomes with Bispecifics in Multiple Myeloma
September 19th 2025
- IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
September 18th 2025